IB-STIM

Serial Number 86937221
Registration 5926831
702

Registration Progress

Application Filed
Mar 11, 2016
Under Examination
Sep 20, 2016
Approved for Publication
Jul 26, 2016
Published for Opposition
Jul 26, 2016
Registered
Dec 3, 2019

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2019-12-03)
Due: Dec 03, 2025 123 days

Trademark Image

IB-STIM

Basic Information

Serial Number
86937221
Registration Number
5926831
Filing Date
March 11, 2016
Registration Date
December 3, 2019
Published for Opposition
July 26, 2016
Drawing Code
4

Status Summary

Current Status
Active
Status Code
702
Status Date
May 6, 2025
Registration
Registered
Classes
010

Rights Holder

NEURAXIS, INC.

03
Address
829 SOUTH ADAMS STREET
VERSAILLES, IN 47042

Ownership History

Innovative Health Solutions, Inc.

Original Applicant
03
Versailles, IN

Innovative Health Solutions, Inc.

Owner at Publication
03
Versailles, IN

Innovative Health Solutions, Inc.

Original Registrant
03
Versailles, IN

NEURAXIS, INC.

New Owner After Registration #1
03
Carmel, IN

NEURAXIS, INC.

New Owner After Registration #2
03
VERSAILLES, IN

Legal Representation

Attorney
Brian J. McGinnis

USPTO Deadlines

Next Deadline
123 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2019-12-03)
Due Date
December 03, 2025
Grace Period Ends
June 03, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

50 events
Date Code Type Description Documents
Jun 22, 2025 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Jun 22, 2025 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Jun 18, 2025 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
May 6, 2025 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
May 6, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
May 6, 2025 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Jan 16, 2025 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Dec 3, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
May 19, 2022 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Oct 27, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Oct 27, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 27, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Oct 27, 2021 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Oct 27, 2021 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Dec 3, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 29, 2019 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Oct 28, 2019 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Oct 2, 2019 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Sep 19, 2019 IUAF S USE AMENDMENT FILED Loading...
Sep 19, 2019 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Mar 22, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 21, 2019 EX5G S SOU EXTENSION 5 GRANTED Loading...
Mar 20, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Mar 17, 2019 EXT5 S SOU EXTENSION 5 FILED Loading...
Mar 17, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 26, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 24, 2018 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jul 24, 2018 EXT4 S SOU EXTENSION 4 FILED Loading...
Jul 24, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 24, 2018 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Mar 20, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 16, 2018 EX3G S SOU EXTENSION 3 GRANTED Loading...
Mar 16, 2018 EXT3 S SOU EXTENSION 3 FILED Loading...
Mar 16, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 23, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 21, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 21, 2017 EX2G S SOU EXTENSION 2 GRANTED Loading...
Aug 21, 2017 EXT2 S SOU EXTENSION 2 FILED Loading...
Mar 18, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 16, 2017 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 16, 2017 EXT1 S SOU EXTENSION 1 FILED Loading...
Mar 16, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 20, 2016 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 26, 2016 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 26, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 6, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 23, 2016 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Jun 13, 2016 ALIE A ASSIGNED TO LIE Loading...
Jun 1, 2016 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 1, 2016 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...

Detailed Classifications

Class 010
Medical apparatus, namely, electrical nerve stimulators; Medical device, namely, a non-implantable modulating frequency generator, providing neuromodulation therapy to cranial and peripheral nerves; Medical apparatus consisting of percutaneously implantable arrays for transmitting current into auricular and peri-auricular tissue; Medical device for peripheral nerve and nerve field stimulation; Medical device consisting of a non-implantable modulating frequency generator and percutaneously implantable needle arrays for transmitting current into auricular and peri-auricular tissue for use in pain management and FGID (functional gastrointestinal disorders), namely, patient stimulator for auricular and peri-auricular peripheral nerve field neuromodulation therapy; Medical apparatus, for peripheral nerve field stimulation in cranial and peripheral nerves and occipital nerve branches, for pain control, FGID, irritable bowel, functional dyspepsia, functional abdominal pain, nausea, functional nausea, abdominal migraine, Crohn's Disease, visceral hypersensitivity, chronic inflammatory bowel disease, changes in FGID co-morbidities, sleep disturbances, psychological disorders, including mood and anxiety, satiety and changes in autonomic nervous system and other types of sympathetically mediated pain
First Use Anywhere: Sep 19, 2019
First Use in Commerce: Sep 19, 2019

Classification

International Classes
010